Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex.

He Y, Lin F, Chipman PR, Bator CM, Baker TS, Shoham M, Kuhn RJ, Medof ME, Rossmann MG.

Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10325-9. Epub 2002 Jul 15.

2.

Interaction of decay-accelerating factor with echovirus 7.

Plevka P, Hafenstein S, Harris KG, Cifuente JO, Zhang Y, Bowman VD, Chipman PR, Bator CM, Lin F, Medof ME, Rossmann MG.

J Virol. 2010 Dec;84(24):12665-74. doi: 10.1128/JVI.00837-10. Epub 2010 Sep 29.

3.

Interaction of decay-accelerating factor with coxsackievirus B3.

Hafenstein S, Bowman VD, Chipman PR, Bator Kelly CM, Lin F, Medof ME, Rossmann MG.

J Virol. 2007 Dec;81(23):12927-35. Epub 2007 Sep 5.

4.

Structural and functional insights into the interaction of echoviruses and decay-accelerating factor.

Pettigrew DM, Williams DT, Kerrigan D, Evans DJ, Lea SM, Bhella D.

J Biol Chem. 2006 Feb 24;281(8):5169-77. Epub 2005 Nov 4.

6.

The structure of echovirus type 12 bound to a two-domain fragment of its cellular attachment protein decay-accelerating factor (CD 55).

Bhella D, Goodfellow IG, Roversi P, Pettigrew D, Chaudhry Y, Evans DJ, Lea SM.

J Biol Chem. 2004 Feb 27;279(9):8325-32. Epub 2003 Nov 21.

7.

Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses.

Bergelson JM, Chan M, Solomon KR, St John NF, Lin H, Finberg RW.

Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6245-8.

8.

Antibody binding to individual short consensus repeats of decay-accelerating factor enhances enterovirus cell attachment and infectivity.

Shafren DR, Dorahy DJ, Thorne RF, Kinoshita T, Barry RD, Burns GF.

J Immunol. 1998 Mar 1;160(5):2318-23.

9.

Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF.

Spiller OB, Goodfellow IG, Evans DJ, Almond JW, Morgan BP.

J Infect Dis. 2000 Jan;181(1):340-3.

PMID:
10608785
10.

Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding.

Clarkson NA, Kaufman R, Lublin DM, Ward T, Pipkin PA, Minor PD, Evans DJ, Almond JW.

J Virol. 1995 Sep;69(9):5497-501.

11.
12.

Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor.

Powell RM, Schmitt V, Ward T, Goodfellow I, Evans DJ, Almond JW.

J Gen Virol. 1998 Jul;79 ( Pt 7):1707-13.

PMID:
9680134
13.

Echovirus infection of rhabdomyosarcoma cells is inhibited by antiserum to the complement control protein CD59.

Goodfellow IG, Powell RM, Ward T, Spiller OB, Almond JW, Evans DJ.

J Gen Virol. 2000 May;81(Pt 5):1393-401.

PMID:
10769083
14.

Echovirus 7 entry into polarized intestinal epithelial cells requires clathrin and Rab7.

Kim C, Bergelson JM.

MBio. 2012 Apr 10;3(2). pii: e00304-11. doi: 10.1128/mBio.00304-11. Print 2012.

15.

Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation.

Powell RM, Ward T, Evans DJ, Almond JW.

J Virol. 1997 Dec;71(12):9306-12. Erratum in: J Virol 1998 Jan;72(1):890.

16.
17.
18.

Two clusters of mutations map distinct receptor-binding sites of echovirus 11 for the decay-accelerating factor (CD55) and for canyon-binding receptors.

Rezaikin AV, Novoselov AV, Sergeev AG, Fadeyev FA, Lebedev SV.

Virus Res. 2009 Oct;145(1):74-9. doi: 10.1016/j.virusres.2009.06.004. Epub 2009 Jun 18.

PMID:
19540285
19.

Specificity of coxsackievirus B3 interaction with human, but not murine, decay-accelerating factor: replacement of a single residue within short consensus repeat 2 prevents virus attachment.

Pan J, Zhang L, Organtini LJ, Hafenstein S, Bergelson JM.

J Virol. 2015 Jan 15;89(2):1324-8. doi: 10.1128/JVI.02798-14. Epub 2014 Nov 12.

20.

The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55).

Karnauchow TM, Tolson DL, Harrison BA, Altman E, Lublin DM, Dimock K.

J Virol. 1996 Aug;70(8):5143-52.

Supplemental Content

Support Center